Nonalcoholic fatty liver disease linked to increased risk for dementia

By

Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according to a study published in Neurology.“Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting 25% of the global population,” Ying Shang, PhD, of the department of…

FDA grants de novo clearance for endoscopic sleeve gastroplasty, bariatric revision devices

By

The FDA has granted de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE endoscopic systems for the treatment of patients with obesity, according to a company press release.These are the first devices authorized by the FDA for endoscopic sleeve gastroplasty and endoscopic bariatric revision procedures.“Obesity affects 108 million adults in…

TNF inhibitors pose ‘modest risk’ for new-onset psoriasis

By

Patients with immune mediated diseases and treated with tumor necrosis factor-alpha inhibitors have a modest risk for new onset psoriasis, according to a study.“Biologics are in most cases effective, and the majority of adverse effects are mild and easy to manage. Paradoxically, psoriasis develops in a number of patients during tumor necrosis factor-alpha inhibition (TNFi)…